A detailed history of Van Strum & Towne Inc. transactions in Novartis Ag stock. As of the latest transaction made, Van Strum & Towne Inc. holds 2,372 shares of NVS stock, worth $273,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,372
Previous 1,972 20.28%
Holding current value
$273,894
Previous $226,000 1.77%
% of portfolio
0.0%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$96.78 - $117.18 $38,712 - $46,872
400 Added 20.28%
2,372 $230,000
Q2 2024

Jul 25, 2024

BUY
$92.57 - $107.37 $182,548 - $211,733
1,972 New
1,972 $209,000
Q3 2023

Nov 08, 2023

BUY
$94.73 - $105.13 $186,807 - $207,316
1,972 New
1,972 $200,000
Q1 2022

May 10, 2022

SELL
$80.11 - $90.62 $193,225 - $218,575
-2,412 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$79.7 - $88.13 $15,940 - $17,626
-200 Reduced 7.66%
2,412 $211,000
Q2 2021

Aug 06, 2021

BUY
$85.24 - $94.15 $222,646 - $245,919
2,612 New
2,612 $238,000
Q1 2021

May 05, 2021

SELL
$83.5 - $98.47 $187,040 - $220,572
-2,240 Closed
0 $0
Q4 2020

Feb 03, 2021

SELL
$78.07 - $94.43 $8,197 - $9,915
-105 Reduced 4.48%
2,240 $212,000
Q2 2020

Jul 14, 2020

BUY
$80.93 - $91.1 $189,780 - $213,629
2,345 New
2,345 $205,000
Q1 2020

Apr 29, 2020

SELL
$70.67 - $99.01 $165,721 - $232,178
-2,345 Closed
0 $0
Q3 2019

Oct 30, 2019

BUY
$85.54 - $94.26 $200,591 - $221,039
2,345 New
2,345 $204,000
Q2 2019

Aug 12, 2019

SELL
$75.4 - $92.8 $161,733 - $199,056
-2,145 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $161,561 - $184,791
2,145 New
2,145 $206,000
Q2 2018

Aug 13, 2018

SELL
$64.91 - $73.36 $165,195 - $186,701
-2,545 Closed
0 $0
Q1 2018

May 02, 2018

SELL
$70.39 - $84.15 $11,262 - $13,464
-160 Reduced 5.91%
2,545 $206,000
Q3 2017

Nov 09, 2017

BUY
$74.14 - $77.27 $200,548 - $209,015
2,705
2,705 $232,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $248B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Van Strum & Towne Inc. Portfolio

Follow Van Strum & Towne Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Strum & Towne Inc., based on Form 13F filings with the SEC.

News

Stay updated on Van Strum & Towne Inc. with notifications on news.